Fosun Pharma Overview

  • Founded
  • 1994

Founded
  • Status
  • Public

  • Employees
  • 36,604

Employees
  • Stock Symbol
  • 600196

Stock Symbol
  • Investments
  • 79

  • Share Price
  • $5.10

  • (As of Thursday Closing)

Fosun Pharma General Information

Description

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices and medical diagnosis, Pharmaceutical distribution and retail, and Other business operations. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHG
Primary Office
  • Number 1289 Yishan Road
  • Building A, Fosun Technology Park
  • Shanghai, 200233
  • China
+86 021 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fosun Pharma Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.10 $5.17 $3.86 - $9.26 $12.8B 2.67B 40M $0.22

Fosun Pharma Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 13,835,617 20,944,720 22,370,136 12,148,353
Revenue 6,646,612 6,040,670 4,386,842 4,136,996
EBITDA 826,992 1,312,827 1,016,906 996,557
Net Income 553,019 733,345 530,181 480,722
Total Assets 14,640,648 14,636,387 12,809,148 10,879,208
Total Debt 4,228,482 3,803,682 3,675,753 3,131,095
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Fosun Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fosun Pharma‘s full profile, request access.

Request a free trial

Fosun Pharma Executive Team (19)

Name Title Board Seat Contact Info
Joel Zhang Ph.D Vice President & Chief Executive Officer of IVD Business Unit
Yifang Wu Chief Executive Officer & Chairman
Wu Xiaolei Vice President & Chief Financial Officer
Shaochuan Zeng Chief Operating Officer
Mei Jingping Executive Vice President & Chief Strategy Officer
You’re viewing 5 of 19 executive team members. Get the full list »

Fosun Pharma Board Members (12)

Name Representing Role Since
0000000 000 Self Board Member 000 0000
0000 000 Fosun Pharma Board Member 000 0000
0000000 0000 Self Board Member 000 0000
000000 00000 Self Board Member 000 0000
0000 00 Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Fosun Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fosun Pharma Investments & Acquisitions (79)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 25-Nov-2022 00000 0000 000.00 Biotechnology
000000000 03-Aug-2022 00000 0000 000.00 Diagnostic Equipment
000000000 24-Mar-2022 00000 0000 000.00 Discovery Tools (Healthcare)
000000 000000 14-Mar-2022 00000 0000 000.00 Drug Discovery
MyGenostics 16-Jan-2022 Later Stage VC 000.00 Laboratory Services (Healthcare)
You’re viewing 5 of 79 investments and acquisitions. Get the full list »

Fosun Pharma Subsidiaries (16)

Company Name Industry Location Founded
XingMeiShengWu Biotechnology Tianjin, China 2020
00000 000000 00000 Corporate Venture Capital Shanghai, China 0000
0000 0000000000000 Pharmaceuticals Shanghai, China 0000
000000 0000000 Therapeutic Devices Taipei, Taiwan 0000
00000 0000000000 0 Acquirer Central, Hong Kong 0000
You’re viewing 5 of 16 subsidiaries. Get the full list »

Fosun Pharma Exits (11)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 26-Mar-2021 00000 00000 00 00000 Completed
  • 6 buyers
000000 00000000000 24-Aug-2020 00000 00000 00 0000 Completed
  • 11 buyers
000000 00000000000 26-Jul-2019 00000 00000 00 0000 Completed
  • 4 buyers
000 0000000 10-Dec-2018 0000 000.00 Completed
  • 00000 000000
HeartCare Medical 01-Jul-2018 Early Stage VC 00.000 Completed
You’re viewing 5 of 11 exits. Get the full list »